Louise Lim

Dr Farah Lim qualified from Imperial School of Medicine in 2004, achieving distinction in clinical practice alongside First Class Honours in molecular biology. She completed her medical oncology training at St Bartholomew’s Hospital, finishing her postgraduate training in 2012. She then undertook further specialist training in immune-oncology for solid tumours, including breast, genitourinary, and lung cancers, which she completed in 2017.

In 2017, Dr Lim was appointed as a Consultant, where she leads the lung immunotherapy and clinical trials unit. She has extensive experience in immune-oncology and has treated a wide range of solid tumours using immunotherapy. Her clinical focus includes lung cancer.